Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer.
about
Intensity-modulated radiotherapy, not 3 dimensional conformal, is the preferred technique for treating locally advanced lung cancerParticle therapy for non-small cell lung tumors: where do we stand? A systematic review of the literatureA critical review of recent developments in radiotherapy for non-small cell lung cancerProton therapy in clinical practiceAdvances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.Evaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung cancer.Particle beam radiation therapy using carbon ions and protons for oligometastatic lung tumors.Clinical implementation of intensity modulated proton therapy for thoracic malignancies.Impact of respiratory motion on worst-case scenario optimized intensity modulated proton therapy for lung cancers.Feasibility of proton transmission-beam stereotactic ablative radiotherapy versus photon stereotactic ablative radiotherapy for lung tumors: a dosimetric and feasibility studyRobust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patients.Robust optimization of intensity modulated proton therapy.Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis.Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.Combined hyperthermia and radiotherapy for the treatment of cancer.The use of proton-beam therapy in the treatment of non-small-cell lung cancer.Accelerated dose escalation with proton beam therapy for non-small cell lung cancer.Novel treatment options in stage I non-small-cell lung cancer.The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for patients with centrally located early stage non-small cell lung cancer or lung metastaProton-based stereotactic ablative radiotherapy in early-stage non-small-cell lung cancer.Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer.Comparison of photon volumetric modulated arc therapy, intensity-modulated proton therapy, and intensity-modulated carbon ion therapy for delivery of hypo-fractionated thoracic radiotherapy.Proton beam therapy in non-small cell lung cancer: state of the art.High Dose Hypofractionated Proton Beam Therapy is a Safe and Feasible Treatment for Central Lung Cancer.Comparison of dose-volume histograms between proton beam and X-ray conformal radiotherapy for locally advanced non-small-cell lung cancer.Dosimetric impact of number of treatment fields in uniform scanning proton therapy planning of lung cancer.Robust optimization in IMPT using quadratic objective functions to account for the minimum MU constraint.Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk.Proton therapy for lung cancer.Clinical results of proton beam therapy for elderly patients with non-small cell lung cancer.Proton therapy for non-small cell lung cancer: Current evidence and future directions.Proton-based chemoradiation for synchronous bilateral non-small-cell lung cancers: A case report.Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.Robust treatment planning with conditional value at risk chance constraints in intensity-modulated proton therapy.Proton therapy for early-stage non-small cell lung cancer (NSCLC).[Stereotactic Body Radiotherapy for Centrally Located Non-small Cell Lung Cancer].Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC): contemporary insights and advancesSmall-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative studyReirradiation for locoregionally recurrent non-small cell lung cancer
P2860
Q26851310-EA084D0E-2104-4A2B-842F-D029ED8D7BA2Q27023426-30BD2ADA-87BD-4F4A-9309-8F8AC7418FB9Q28079625-C2A14046-62DC-4AE9-A1F2-9ABD9BB8B318Q33579648-F7270402-76FE-4721-A88F-0C7CD1C7B842Q33645619-77FC5453-A41D-4E41-A8A8-3CCB06FE2B6FQ33860897-9AFA3B10-214B-4C63-B91A-034160C70714Q34123571-4D17FCF2-2DED-46F8-82C3-175919A0D404Q34615702-BFDA13D1-6DDB-451E-91F7-C53EE8BBB321Q35163969-B058E47D-5364-451A-A438-6BB1BE72F62BQ35179720-B4AFFF61-231B-4CD8-95FC-87C8FD71B199Q35449770-C4602FE9-7AF3-40CA-9EE7-55EF25346727Q35764013-37CC7050-D478-477C-B45C-BBA592A4D339Q36382039-5FD087F5-9C38-42C9-88BA-37ACBFBFE147Q36805626-AEBC6EFA-60B4-4B02-BDFA-34719C8CABCEQ37148144-9F65B7DC-BD5B-4D43-BA13-211BD92BCA93Q38088273-793347DA-24AF-499B-94C0-3B478C37DA79Q38201057-4B11A577-0CD0-4F48-9314-D570035484D8Q38220335-EF0A4D0E-8DE1-4E35-B4CF-1A35E971C292Q38227883-110EF894-B051-4D9E-B4E3-FF156B3AE871Q38241214-6F6987F7-0379-411F-9B2D-6D69606D3747Q38990272-8696A7EE-BD2D-4713-95CC-BB07A3607035Q41431618-B347EF1A-23F0-47FC-A297-31FD695EAB5DQ41546002-46616F7C-3FB7-4286-994C-1D10CE1F2AA8Q41678140-A4E219BE-BB2E-4A87-A357-D29A3A3761A7Q42584254-F07AA58C-EE69-47B7-9DDA-328630EF3F19Q43057931-8065F7CD-4FF9-41B3-B310-815CE80B2D6CQ47606252-8C143D71-1DF7-4BF8-B7EE-2F579CB76307Q47662148-8B6DD078-9F11-4A37-A402-7C6BB48BA1F6Q48247127-B16AFFA3-0009-4745-A7F8-22CFC24DA7D7Q49286208-5D3E81A0-0816-4079-AD4B-48CE05262578Q50050183-0AF2B1FD-67C6-48BA-BB20-2FC68F0D4234Q50050629-20C79C0A-AE56-4020-936B-8E9F89B4E705Q52650857-D8F4D940-E5C5-48D8-9BCC-DEDDB737CCD5Q55080575-4E6D64A2-4DD5-49C5-875D-B2105750EB8FQ55208073-50419F1C-8ADF-4EA4-AFE6-66FD999CE74BQ55441971-1EA92C91-D566-4D17-95E2-FFB1A10653C3Q57172947-31877926-FA16-4FD5-A61F-383001E77CDBQ57453413-17F2E858-74CB-4536-904D-98760FF780A2Q58804832-EE32D4B2-CD67-4478-882E-47CCA416BF13
P2860
Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Proton stereotactic body radia ...... I non-small-cell lung cancer.
@ast
Proton stereotactic body radia ...... I non-small-cell lung cancer.
@en
Proton stereotactic body radia ...... I non-small-cell lung cancer.
@nl
type
label
Proton stereotactic body radia ...... I non-small-cell lung cancer.
@ast
Proton stereotactic body radia ...... I non-small-cell lung cancer.
@en
Proton stereotactic body radia ...... I non-small-cell lung cancer.
@nl
prefLabel
Proton stereotactic body radia ...... I non-small-cell lung cancer.
@ast
Proton stereotactic body radia ...... I non-small-cell lung cancer.
@en
Proton stereotactic body radia ...... I non-small-cell lung cancer.
@nl
P2093
P2860
P1476
Proton stereotactic body radia ...... I non-small-cell lung cancer.
@en
P2093
Joe Y Chang
Steven P Register
Xiaodong Zhang
P2860
P304
P356
10.1016/J.IJROBP.2010.03.012
P407
P50
P577
2010-07-07T00:00:00Z